Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 50 of 144 pages ‹ First < 48 49 50 51 52 > Last ›
HSL11774
Vitry A, Lexchin J, Mansfield PR.
Is Australia's National Medicines Policy Failing? The Case of Cox-2 Inhibitors
Int J Health Serv 2007 Oct; 37:(4):735 - 744
http://baywood.metapress.com/app/home/contribution.asp?referrer=parent&backto=issue,9,13;journal,1,148;linkingpublicationresults,1:300313,1
HSL11793
Davis J.
The Effect of Qualifying Language on Perceptions of Drug Appeal, Drug Experience, and Estimates of Side-Effect Incidence in DTC Advertising.
J Health Commun 2007 Oct-Nov; 12:(7):607-22
http://www.informaworld.com/smpp/content?content=10.1080/10810730701615164
HSL11794
Steinman MA, Baron RB.
Is continuing medical education a drug-promotion tool?: YES
Can Fam Physician. 2007 Oct; 53:(10):1650-3
http://www.cfp.ca/cgi/content/full/53/10/1650
HSL11795
Marlow B.
Is continuing medical education a drug-promotion tool?: NO.
Can Fam Physician 2007 Oct; 53:(10):1650-2,
http://www.cfp.ca/cgi/content/full/53/10/1650-a
HSL11827
MacLean DS.
Drug Overuse: ‘Get Your Doctors to Fix This’
Caring for the Ages 2007 Oct; 8:(10):5
HSL11838
Light D.
Misleading Congress about Drug Development
Journal of Health Politics, Policy and Law 2007 Oct; 32:(5):895-913
http://web.archive.org/web/20090610012035/http://www.bioethics.upenn.edu/People/?last=Light&first=Donald
HSL11851
Lohr KN.
Emerging methods in comparative effectiveness and safety: symposium overview and summary.
Med Care 2007 Oct; 45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00003
HSL11852
Maclure M, Carleton B, Schneeweiss S.
Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations.
Med Care 2007 Oct; 45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00010
HSL11853
Sturmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S.
Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.
Med Care 2007 Oct; 45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00025
HSL11854
Segal JB, Griswold M, Achy-Brou A, Herbert R, Bass EB, Dy SM, Millman AE, Wu AW, Frangakis CE.
Using propensity scores subclassification to estimate effects of longitudinal treatments: an example using a new diabetes medication.
Med Care 2007 Oct; 45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00024
HSL11857
Ganz PA, Goodwin PJ.
Health-related quality of life measurement in symptom management trials.
J Natl Cancer Inst Monogr 2007 Oct; (37):47-52
http://jncimono.oxfordjournals.org/cgi/content/abstract/2007/37/47
HSL11858
Rock EP, Scott JA, Kennedy DL, Sridhara R, Pazdur R, Burke LB.
Challenges to use of health-related quality of life for food and drug administration approval of anticancer products.
J Natl Cancer Inst Monogr 2007 Oct; (37):27-30
http://jncimono.oxfordjournals.org/cgi/content/abstract/2007/37/27
HSL11859
Thornton RG.
Preemption, tort reform, and pharmaceutical claims: Part one: Who will become the pharmaceutical industry's insurers (or is it prescribing physicians and we do not know it?)
Proc (Bayl Univ Med Cent). 2007 Oct; 20:(4):418-22
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17948120
HSL11862
Ridinger MH.
Nutraceuticals: miracle or meme?
Clin Pharmacol Ther 2007 Oct; 82:(4):352-6
http://www.nature.com/clpt/journal/v82/n4/abs/6100354a.html;jsessionid=6C8C2514729C6954195E71C9E7A10812
HSL11865
Biron P, Lévesque P, Plaisance M.
Pharmas-co-dependence exposed: Would it be time to say, 'No thanks'?
Can Fam Physician 2007 Oct; 53:(10):1635 - 1637
http://www.cfp.ca/cgi/content/full/53/10/1635
HSL11882
Cassels A.
Big Bucks Big Pharma: New DVD exposes pharma’s ruthless marketing strategies
Common Ground 2007 Oct
http://commonground.ca/iss/195/cg195_bigbucks.shtml
HSL11924
Fitz MM, Homan D, Reddy S, Griffith CH 3rd, Baker E, Simpson KP.
The hidden curriculum: medical students' changing opinions toward the pharmaceutical industry.
Acad Med 2007 Oct; 82:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00001888-200710001-00001
HSL11936
Fallat ME, Glover J; American Academy of Pediatrics, Committee on Bioethics.
Professionalism in pediatrics.
Pediatrics 2007 Oct; 120:(4):e1123-33
http://pediatrics.aappublications.org/cgi/content/full/120/4/e1123
HSL12028
Nelson R.
When ads trump evidence: is direct-to-consumer advertising leading practice?
Am J Nurs 2007 Oct; 107:(10):25-6
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000446-200710000-00018
HSL12030
Avanzini G, Engel J Jr.
Dealing with drug dependency: a commentary on ILAE's partnership with the pharmaceutical industry.
Epilepsia 2007 Oct; 48:(10):1821-4 Epub 2007 Aug 7
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1528-1167.2007.01255.x
HSL12092
G & S Research Inc
RepReview Pharma 2007 Insights from the Front Line: Sales Representatives and Managers
: G & S Research Inc 2007 Oct
http://www.repreview2007.com/RepReview2007_Synopsis.pdf
HSL12122
Hondeghem LM, De Clerck F, Camm J.
Short patent lives jeopardize drug and patient safety.
J Cardiovasc Pharmacol 2007 Oct; 50:(4):353-7
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005344-200710000-00001
HSL12126
Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA.
Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES).
Med Care 2007 Oct; 45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00017
HSL12127
Crystal S, Akincigil A, Bilder S, Walkup JT.
Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies.
Med Care 2007 Oct; 45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00012
HSL12156
Oppenheimer J, Aaronson D.
Impact of recent black box warnings in the allergy world.
Ann Allergy Asthma Immunol 2007 Oct; 99:(4):364-6
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17941285&dopt=AbstractPlus
HSL12160
FDA and industry happenings.
J Interv Cardiol. 2007 Oct; 20:(5):406-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1540-8183.2007.00288.x
HSL12205
Giraldi A, Kristensen E.
Medical solutions have improved the treatment of sexological problems and created more demand for sexological care.
J Sex Marital Ther 2007 Oct-Dec; 33:(5):433-7
http://www.informaworld.com/smpp/content?content=10.1080/00926230701477154
HSL12251
Barlow K.
Do we dare use the 'S' word?
Health Care Strateg Manage 2007 Oct; 25:(10):15-6
http://www.ncbi.nlm.nih.gov/pubmed/17983034
HSL12252
Szczypka G, Wakefield MA, Emery S, Terry-McElrath YM, Flay BR, Chaloupka FJ.
Working to make an image: an analysis of three Philip Morris corporate image media campaigns.
Tob Control 2007 Oct; 16:(5):344-50
http://tobaccocontrol.bmj.com/cgi/content/full/16/5/344
HSL12286
Naito S, Furuta S, Yoshida T, Kitada M, Fueki O, Unno T, Ohno Y, Onodera H, Kawamura N, Kurokawa M, Sagami F, Shinoda K, Nakazawa T, Yamazaki T.
Current opinion: safety evaluation of drug metabolites in development of pharmaceuticals.
J Toxicol Sci 2007 Oct; 32:(4):329-41
http://www.jstage.jst.go.jp/article/jts/32/4/32_329/_article
HSL12287
Rankin RC.
The high cost of free lunch.
Obstet Gynecol 2007 Oct; 110:(4):932
http://www.greenjournal.org/cgi/content/full/110/4/932
HSL12288
Randall DA.
The high cost of free lunch.
Obstet Gynecol 2007 Oct; 110:(4):932
http://www.greenjournal.org/cgi/content/full/110/4/932-a
HSL12289
Frohlich EP.
The high cost of free lunch.
Obstet Gynecol 2007 Oct; 110:(4):931
http://www.greenjournal.org/cgi/content/full/110/4/931
HSL12290
Campbell WA.
The high cost of free lunch.
Obstet Gynecol 2007 Oct; 110:(4):931-2
http://www.greenjournal.org/cgi/content/full/110/4/931-a
HSL12602
Galm U, Shen B.
Natural product drug discovery: the times have never been better.
Chem Biol 2007 Oct; 14:(10):1098-104
http://linkinghub.elsevier.com/retrieve/pii/S1074-5521(07)00332-8
HSL12678
Grieve AP.
25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel.
Pharm Stat 2007 Oct-Dec; 6:(4):261-81
http://www3.interscience.wiley.com/cgi-bin/abstract/116833172/ABSTRACT?CRETRY=1&SRETRY=0
HSL12786
Prescriptions for confusion: Some retailers have improved the pill bottle, but the written information that comes with medications is confusing.
Harv Health Lett. 2007 Oct; 32:(12):1-2
http://www.ncbi.nlm.nih.gov/pubmed/18246620
HSL12800
Latimer AE, Salovey P, Rothman AJ.
The effectiveness of gain-framed messages for encouraging disease prevention behavior: is all hope lost?
J Health Commun 2007 Oct-Nov; 12:(7):645-9
http://www.informaworld.com/smpp/content?content=10.1080/10810730701619695
HSL12801
O'Keefe DJ, Jensen JD.
The relative persuasiveness of gain-framed and loss-framed messages for encouraging disease prevention behaviors: a meta-analytic review.
J Health Commun 2007 Oct-Nov; 12:(7):623-44
http://www.informaworld.com/smpp/content?content=10.1080/10810730701615198
HSL12923
Mills S.
Re: The frequency and impact of restless legs syndrome in primary care.
Ir Med J 2007 Oct; 100:(9):606
http://www.ncbi.nlm.nih.gov/pubmed/18196890?dopt=Abstract
HSL13164
Anders TF.
The pharmaceutical industry, academic medicine, and the FDA.
J Child Adolesc Psychopharmacol 2007 Oct; 17:(5):727-30
http://www.liebertonline.com/doi/abs/10.1089/cap.2007.0093
HSL13251
Bonnemain B.
[Pharmaceutical and parapharmaceutical advertising of Annales vertes in 1927].
Rev Hist Pharm (Paris) 2007 Oct; 55:(355):307-28
http://www.ncbi.nlm.nih.gov/pubmed/18348495
HSL13386
Satyanarayana K, Srivastava S.
Poverty, health & intellectual property rights with special reference to India.
Indian J Med Res 2007 Oct; 126:(4):390-406
http://www.icmr.nic.in/ijmr/2007/october/1016.pdf
HSL14354
Chaudhry S, Chaudhry S, Chaudhry K.
Point of sale tobacco advertisements in India.
Indian J Cancer 2007 Oct-Dec; 44:(4):131-6
http://www.indianjcancer.com/article.asp?issn=0019-509X;year=2007;volume=44;issue=4;spage=131;epage=136;aulast=Chaudhry
HSL11638
Oboh M.
Pfizer faces $8.5 bln suit over Nigeria drug trial
Reuters 2007 Sep 30
http://www.thisislondon.co.uk/standard/article-23414491-pfizer-is-sued-over-nigerian-drug-trials.do
HSL11656
Ten Things Wrong With Medical Journals
The Last Psychiatrist (blog) 2007 Sep 30
http://thelastpsychiatrist.com/2007/09/ten_things_wrong_with_medical.html
HSL12402
Larsson DG, de Pedro C, Paxeus N.
Effluent from drug manufactures contains extremely high levels of pharmaceuticals.
J Hazard Mater 2007 Sep 30; 148:(3):751-5
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TGF-4P4FV8H-6&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=7447b86be93edc1676114c3ebcc42b0a
HSL11599
Briggs AH.
New methods of analysing cost effectiveness
BMJ 2007 Sep 29; 335:(7621):622
http://www.bmj.com/cgi/content/short/335/7621/622?etoc
HSL11600
Moynihan R.
Healthcare giant advertises to children in classrooms
BMJ 2007 Sep 29; 335:(7621):637
http://www.bmj.com/cgi/content/short/335/7621/637-b?etoc
HSL11601
Lilford RJ, Brown CA, Nicholl J
Use of process measures to monitor the quality of clinical practice
BMJ 2007 Sep 29; 335:(7621):648
http://www.bmj.com/cgi/content/short/335/7621/648?etoc
HSL11620
Harris G.
Ban Sought on Cold Medicine for Very Young
New York Times 2007 Sep 29
http://www.nytimes.com/2007/09/29/health/29fda.html?_r=1&hp&oref=slogin
HSL11691
Wittkowsky AK.
Dietary supplements, herbs and oral anticoagulants: the nature of the evidence.
J Thromb Thrombolysis 2007 Sep 29; Epub ahead of print
http://www.springerlink.com/content/137351756p547148/
HSL11586
Saltzman J.
Bristol-Myers Squibb to pay $515 million for doctor kickback scheme
The Boston Globe 2007 Sep 28
http://www.boston.com/news/globe/city_region/breaking_news/2007/09/bristolmyers_sq.html
HSL11587
Harris G.
Report Assails F.D.A. Oversight of Clinical Trials
New York Times 2007 Sep 28
http://www.nytimes.com/2007/09/28/health/policy/28fda.html
HSL11603
Rost P.
Bristol-Myers Squibb: Second drug company to pay more than $1 billion in fines.
BrandweekNRx 2007 Sep 28
http://www.brandweeknrx.com/2007/09/bristol-myers-s.html
HSL11604
Sales rep mirroring declines
PMLive.com 2007 Sep 28
http://www.pmlive.com/index.cfm?showArticle=1&ArticleID=6036
HSL11605
Report reveals best-in-class, cross-functional marketing teams
PMLive.com 2007 Sep 28
http://www.pmlive.com/index.cfm?showArticle=1&ArticleID=6038
HSL11625
Bristol-Myers Squibb to Pay More Than $515 Million to Resolve Allegations of Illegal Drug Marketing and Pricing
US Dept of Justice 2007 Sep 28
http://www.usdoj.gov/opa/pr/2007/September/07_civ_782.html
HSL11636
Clarke T.
Novartis has no plans to split CEO, chairman roles
Reuters 2007 Sep 28
http://www.reuters.com/article/health-SP/idUSN2820798120071001?pageNumber=1
HSL11637
Summary Box: Vioxx Anniversary
Associated Press 2007 Sep 28
http://www.bookrags.com/news/summary-box-no-end-in-sight-for-vioxx-moc/
HSL11679
FDA Takes Action to Stop Marketing of Unapproved Hydrocodone Products
PharmaLive 2007 Sep 28
http://pharmalive.com/news/index.cfm?articleID=479560&categoryid=43
HSL11692
Price M, Cameron R, Butow P.
Communicating risk information: The influence of graphical display format on quantitative information perception-Accuracy, comprehension and preferences.
Patient Educ Couns 2007 Sep 28;
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TBC-4PT2FP3-1&_user=10&_coverDate=10%2F01%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=d4e79c1c51a05fb851e08fa4e94fd203
HSL11693
Magrini N, Formoso G, Marata AM, Capelli O, Maestri E, Voci C, Nonino F, Brunetti M, Paltrinieri B, Maltoni S, Magnano L, Bonacini MI, Daya L, Viani N.
Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in Italy.
BMC Health Serv Res 2007 Sep 28; 7:(1):158
http://www.biomedcentral.com/1472-6963/7/158
HSL11571
Silverman E.
Glaxo CEO Knew Doc Was Intimidated
Pharmalot 2007 Sep 27
http://www.pharmalot.com/2007/09/avandiagate-jp-knew-doctor-was-intimidated/#more-9538
HSL11574
Japsen B.
Firms to study why some vulnerable to drug reactions
Chicago Tribune 2007 Sep 27
http://www.chicagotribune.com/business/chi-thu_notebook_0927sep27,0,6328446.story
HSL11596
Prexige Receives 'Not Approvable' Letter in the US Despite Being One of the Most Studied COX-2 Inhibitors
PharmaLive 2007 Sep 27
http://pharmalive.com/news/index.cfm?articleID=478924&categoryid=9&newsletter=1
HSL11597
Johnson LA.
Drug Makers, FDA Partner on Drug Safety
Associated Press 2007 Sep 27
http://biz.yahoo.com/ap/070927/side_effects_collaboration.html?.v=1
HSL11578
Wang PS, Simon GE, Avorn J, Azocar F, Ludman EJ, McCulloch J, Petukhova MZ, Kessler RC.
Telephone Screening, Outreach, and Care Management for Depressed Workers and Impact on Clinical and Work Productivity Outcomes: A Randomized Controlled Trial
JAMA 2007 Sep 26; 298:(12):1401-1411
http://jama.ama-assn.org/cgi/content/full/298/12/1401
HSL11598
Gruber A.
Many drugs slip through regulatory 'black hole'
CNN.com 2007 Sep 26
http://www.cnn.com/2007/HEALTH/conditions/09/26/unapproved.drugs/index.html?iref=mpstoryview
HSL11654
Kukla R.
How Do Patients Know?
Hastings Cent Rep. 2007 Sep 26; 37:(5):27-35
http://www.medscape.com/viewarticle/563286_1
HSL11680
Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
PharmaLive 2007 Sep 26
http://pharmalive.com/news/index.cfm?articleID=478694&categoryid=43
HSL11694
Lee YC, Huang KH, Huang YT.
Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.
Health Policy Plan 2007 Sep 26; epub ahead of print
http://heapol.oxfordjournals.org/cgi/content/abstract/czm035v1
HSL11572
Sismondo S.
Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?
PLoS Medicine 2007 Sep 25; 4:(9):e286
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040286
HSL11573
Allan GM, Lexchin J, Wiebe N.
Physician Awareness of Drug Cost: A Systematic Review
PLoS Med 2007 Sep 25; 4:(9):e283
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040283
HSL11576
Bartz D, Vicini J.
US Supreme Court agrees to hear Pfizer patent case
Reuters 2007 Sep 25
http://www.reuters.com/article/health-SP/idUSN2538320520070925
HSL11577
Feder BJ.
Johnson & Johnson’s Risky Tactic Fails in Patent Fight
New York Times 2007 Sep 25
http://www.nytimes.com/2007/09/25/business/25stent.html
HSL11622
Cassels A.
W is for Wilbert’s wee willy (which tends to go off prematurely)
CMAJ 2007 Sep 25; 177:(7):816
http://www.cmaj.ca/cgi/reprint/177/7/816
HSL11626
Cohen R.
Relief -- and some bitter pills
The New Jersey Star-Ledger 2007 Sep 25
http://www.nj.com/business/ledger/index.ssf?/base/business-1/1190694902193000.xml&coll=1&thispage=1
HSL13373
Lewis S.
The Power of Pills: Social, Ethical & Legal Issues in Drug Development, Marketing & Pricing - Edited by Jillian C. Cohen, Patricia Illingworth & Udo Schüklenk
Dev World Bioeth. 2007 Sep 25; Epub ahead of print
http://www.ncbi.nlm.nih.gov/pubmed/18370933?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11584
Bass A.
Suicide rates as a public relations tool
The Boston Globe 2007 Sep 24
http://www.boston.com/news/globe/editorial_opinion/oped/articles/2007/09/24/suicide_rates_as_a_public_relations_tool/
HSL11653
Kassirer JP.
By Financial Disclosures, We're Fixing the Wrong Problem
Medscape General Medicine 2007 Sep 24
http://www.medscape.com/viewarticle/562838?src=mp
HSL11511
Burnand A.
Misconceptions about PPRS
BMJ 2007 Sep 22; 335:(7620):578
http://www.bmj.com/cgi/content/short/335/7620/578?etoc
HSL11512
Iheanacho I.
Drug pricing: Author's reply
BMJ 2007 Sep 22; 335:(7620):578
http://www.bmj.com/cgi/content/short/335/7620/578-a?etoc
HSL11513
Messori A.
PPRS is not NICE
BMJ 2007 Sep 22; 335:(7620):578
http://www.bmj.com/cgi/content/short/335/7620/578-b?etoc
HSL11514
Lenzer J.
Advert for breast cancer gene test triggers inquiry
BMJ 2007 Sep 22; 335:(7620):579
http://www.bmj.com/cgi/content/short/335/7620/579-a?etoc
HSL11515
Spurgeon D.
Number of serious adverse events doubles in seven years in US
BMJ 2007 Sep 22; 335:(7620):585
http://www.bmj.com/cgi/content/short/335/7620/585-a?etoc
HSL11516
Kmietowicz Z.
NICE should have bigger role in guiding NHS, says report
BMJ 2007 Sep 22; 335:(7620):585
http://www.bmj.com/cgi/content/short/335/7620/585-b?etoc
HSL11517
Hawkes N.
Have charities been silenced by government gold?
BMJ 2007 Sep 22; 335:(7620):592
http://www.bmj.com/cgi/content/short/335/7620/592?etoc
HSL11563
Blomeley S.
State plans lawsuit against drug firms
Arkansas Democrat-Gazette 2007 Sep 22
http://www.nwanews.com/adg/News/202128/
HSL11567
When naming a drug, it's an inexact science
The Indianapolis Star 2007 Sep 22
http://www.indystar.com/apps/pbcs.dll/article?AID=/20070922/BUSINESS/709220429/-1/LOCAL17
HSL11627
Henderson D.
FDA considers reforming use, selection of advisory panels
The Boston Globe 2007 Sep 22
http://www.boston.com/business/globe/articles/2007/09/22/fda_considers_reforming_use_selection_of_advisory_panels/
HSL11518
Saul S.
Helped by Generics, Inflation of Drug Costs Slows
New York Times 2007 Sep 21
http://www.nytimes.com/2007/09/21/business/21generic.html?_r=1&oref=slogin
HSL11533
Congress finally passes bill to give FDA sweeping powers
Pharma Times 2007 Sep 21
http://www.pharmatimes.com/WorldNews/ViewArticle.aspx?id=11798
HSL11537
Psychotropic drug Ritalin may be barred from depression patients
Japan Economic Newswire 2007 Sep 21
http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1521581&contentType=sentryarticle&channelID=33
HSL11538
Blum J.
Drug Safety Measure Clears Congress, Goes to Bush
Bloomberg News 2007 Sep 21
http://www.bloomberg.com/apps/news?pid=20601202&sid=a.xzwPdQe_Zs&refer=healthcare
HSL11568
Mantone J.
Advertising Allies Turn Tide for Pharma
The Wall Street Journal Health Blog 2007 Sep 21
http://blogs.wsj.com/health/2007/09/21/advertising-allies-turn-tide-for-pharma/
HSL11585
Lane C.
Shy on Drugs
New York Times 2007 Sep 21
http://www.nytimes.com/2007/09/21/opinion/21lane.html
HSL11624
Silverman E.
Why Tougher DTC Restrictions Were Killed
Pharmalot 2007 Sep 21
http://www.pharmalot.com/2007/09/why-tougher-dtc-restrictions-were-killed/
HSL11534
Bridges A.
Congress OKs drug safety bill
Associated Press 2007 Sep 20
http://news.yahoo.com/s/ap/20070921/ap_on_go_co/drug_safety
HSL11536
Reinberg S.
Americans Confused About FDA and Drug Safety
HealthDay News 2007 Sep 20
http://www.healthday.com/Article.asp?AID=608430
Page 50 of 144 pages ‹ First < 48 49 50 51 52 > Last ›
